IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 222 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,885 | -69.8% | 1,338 | -66.7% | 0.00% | -100.0% |
| Q2 2023 | $42,709 | +27.9% | 4,014 | +26.5% | 0.00% | 0.0% |
| Q1 2023 | $33,380 | +646.3% | 3,173 | +778.9% | 0.00% | – |
| Q4 2022 | $4,473 | -10.5% | 361 | -20.5% | 0.00% | – |
| Q3 2022 | $5,000 | -44.4% | 454 | -41.5% | 0.00% | – |
| Q2 2022 | $9,000 | +50.0% | 776 | +68.3% | 0.00% | – |
| Q1 2022 | $6,000 | +20.0% | 461 | +9.8% | 0.00% | – |
| Q4 2021 | $5,000 | 0.0% | 420 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | -28.6% | 420 | -19.1% | 0.00% | – |
| Q2 2021 | $7,000 | +40.0% | 519 | +27.2% | 0.00% | – |
| Q1 2021 | $5,000 | +66.7% | 408 | +61.3% | 0.00% | – |
| Q4 2020 | $3,000 | +50.0% | 253 | -7.3% | 0.00% | – |
| Q3 2020 | $2,000 | +100.0% | 273 | +326.6% | 0.00% | – |
| Q2 2020 | $1,000 | – | 64 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |